The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

Lady Gaga is set to take on Chappell Roan for Number 1 this week – Abracadabra (2) is less than 1,400 chart units away from Pink Pony Club (1), which became the first UK chart-topper for pop ...

Pediatric doses associated with consistent exposure across age are still unknown. Therefore, we aim to identify a dosing strategy for ivermectin treatment in both pre-school-aged children (2–5 years ...

The dosage for Abilify (aripiprazole) may depend on the condition being treated and the form of the drug prescribed. Other factors, including your age and how you respond to treatment, may affect ...

Otulfi® is an ustekinumab biosimilar for the reference product Stelara® (ustekinumab ... a 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringe for injection and a 130 mg/26 mL (5 mg ...

FYB202/Otulfi® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United ... a 45 mg/0.5 mL and 90 mg/mL single-dose prefilled syringe for injection and a 130 mg/26 mL (5 mg/mL ...

Quercetin has most often been used by adults in doses of 250-1000 mg by mouth daily for up to 12 weeks. Speak with a healthcare provider to find out what dose might be best for a specific condition.

As a major component of the Connect 360 Autoimmune Program expansion, SmithRx will help employer clients and their employees adopt biosimilars, representing over 95% savings compared to Stelara ...